AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Norcod

Quarterly Report Jun 12, 2025

3675_rns_2025-06-12_d3b0e941-5bf8-479c-8b24-e985f2556a56.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Q1-2025

Financial report

Q1 2025 Highlights

  • 193 MNOK in revenues, up 63% from 118 MNOK in Q1-24
  • 43 MNOK in operating loss, corresponding to a 43% improvement in EBITmargin from Q1-24
  • Production cost at sea 44,0 NOK per kg WFE
  • 3 929 tons WFE harvested, up 42% from 2 765 tons WFE in Q1-24
  • Maturation closely monitored and handled proactively in close collaboration with the Directorate of Fisheries
  • To fund annual production capacity of up to 25,000 tonnes WFE towards 2030, Norcod has during Q1-25 secured a funding of approximately 300 MNOK through a combination of increased debt commitment and a private placement.

Post Q1 2025 Highlights

  • Completed subsequent repair issue to ensure equal treatment of shareholders after the private placement
  • Optimising operations and building a solid foundation for profitable growth, in line with the company's revised growth strategy.

Operational update

Operational Update

During the quarter, Norcod has harvested a total of 3 929 tons, from Frosvika and Labukta. All biomass was processed at Norcod's harvesting facility Kråkøy Slakteri.

For units that were fully harvested during Q1, the biological feed conversion ratio (BFCR) came in at 1.1 with an economic feed conversion ratio (EFCR) of 1.33.

86.6% of the harvested volume in Q1 holds superior quality.

Biomass at sea reduced temporarily during Q1 to optimise and balance long term production plans and growth. We will see an increase in standing biomass during the second half of the year and are on track to harvest approximately 8 000 tonnes in 2025.

Preventing maturation remains essential to reducing potential interaction between farmed and wild cod. We have maintained frequent gonad monitoring in close collaboration with the Directorate of Fisheries. These measures help identify early signs of maturation and have allowed us to act proactively and responsibly, including adjusting harvest plans when necessary and ahead of official notifications from the Directorate.

Total export volume during the quarter Standing biomass at the end of the quarter

At the end of the quarter, Norcod's biomass at sea totaled 4 013 tonnes. Net growth during the quarter was 1 195 tonnes. According to officially reported statistics by the Norwegian Seafood Council and company estimates, Norcod's share of total export volume of harvested farmed cod during the quarter was 61%. At the end of the quarter, Norcod held 28% of the total biomass volume.

Source: Directorate of Fisheries, Norwegian Seafood Council and company estimates.

Optimising operations and building a solid foundation for profitable growth

Norcod is working diligently to lay a solid foundation for profitable growth and reduce risk of future incidents, enabling the company to deliver on the revised business strategy that was developed through Q4 2024 and Q1 2025. This includes:

  • Applications for new farming sites, applications to increase MAB at existing sites and proactively pursuing other opportunities to increase site capacity.
  • Optimising and securing fry and juvenile capacity from the land-based phase.
  • Norcod remains firmly committed to its zero-escape vision and continues to strengthen procedures, inspections and equipment standards to prevent future incidents. This includes implementing a revised net strategy, inspired by the sea bream industry, with stronger nets that are changed during the cycle.
  • Several lighting regime measures are being implemented to improve management of maturation, including power supply, monitoring and technical redundancy.
  • Implementing a higher level of control mechanisms, optimising the feeding regime as well as refining production processes.

Financial Update

Highlights

Harvest volume (tonnes WFE)

Revenues (MNOK)

Production cost at sea (NOK per kg WFE)

Available credit and cash at hand (MNOK)

Available credit Cash at hand

Biological assets (MNOK) Biomass at sea (tonnes)

Non-current assets Inv. and biological assets Other current assets Cash

Balance sheet development – Assets (MNOK) Balance sheet development – Equity and liabilities (MNOK)

Q1-2025 Q1-2024 Y/Y-% FY
2024
Operating
revenue
193
454
118
469
63
3
%
,
397
183
Production
cost*
-172
769
-110
156
-56
8
%
,
-382
866
Other
operating
expenses
-71
589
-56
177
-27
4
%
,
-208
130
excl
and
adjustment
of
biomass
EBIT
non-recurring
items
FV
-50
904
-47
864
-6
4
%
,
-193
813
Non-recurring
items
-2
401
0 -28
896
FV-adjustment
of
biomass
10
667
2
264
371
2
%
,
17
740
EBIT -42
638
-45
600
%
6
5
,
-204
969
EBIT-margin %
-22
0
,
%
-38
5
,
%
42
7
,
%
-51
6
,
volume
Harvest
WFE
3
929
2
765
%
42
1
,
8
333
per kg*
Production
NOK
cost
44
0
,
39
8
,
%
10
6
,
45
9
,

* before harvest, wellboat, freight and non-production admin

Profit and Loss First Quarter 2025

Operating revenues for the first quarter were 193 MNOK based on a harvested volume of 3.929 tonnes, up from 118 MNOK and a harvested volume of 2.765 tonnes in Q1-24. Operating expenses ended at 247 MNOK, up from 166 MNOK in Q1-24. The increase is mainly explained by significantly higher harvest volume compared to the corresponding quarter last year, and some cost related to building the foundation for upscaling and profitable growth.

Production cost per kg increased from 39.8 NOK per kg WFE in Q1-24 to 44.0 NOK per kg WFE in Q1-25. The increase is mainly explained by earlier harvesting due to handling of maturation. However, Q1 production cost represents an improvement from the 2024 yearly average of 45.9 NOK per kg WFE.

Operating loss ended at 43 MNOK, down from 46 MNOK in the corresponding quarter last year. Net loss for the period ended at 50 MNOK, down from 55 MNOK in Q1-24.

The company is continuing to improve its financial performance and develop a more efficient and commercially oriented business. This is reflected in the revenue growth of 63%, which also has resulted in reduced operating losses compared to the corresponding quarter last year.

Balance Sheet Development

Total assets ended at 564 MNOK in Q1-25, down from 783 MNOK in Q1-24. The change from last year is mainly explained by a decrease in biological assets due to the increased harvesting, low level of new investments in property, plant, and equipment, and use of cash for downpayment of the overdraft facility.

Available credit at the end of the quarter is 165 MNOK, and together with 9 MNOK in cash at hand the total available funds ended at 174 MNOK, up from 143 MNOK in Q1-24. The new funding secured during the quarter further improves the company's financial position, giving increased financial and operational headroom to continue with the revised growth plan.

Total equity ended at 262 MNOK, down from 334 MNOK in Q1-24.

Total non-current liabilities ended at 121 MNOK in Q1-25, down from 150 MNOK in Q1-24. Current interest-bearing debt ended at 52 MNOK, down from 128 MNOK in Q1-24. Total current liabilities ended at 181 MNOK in Q1-25, down from 299 MNOK in Q1-24. The change is mainly driven by increased cash flows from operations due to the harvesting level, combined with supply of liquid funds from the private placement executed during the quarter .

Cash Flows

Net cash flows from operating activities were close to neutral with -4 MNOK in Q1-25, compared to -41 MNOK in Q1-24. The increased harvesting and favorable development in sales prices contributed to the improvement of cash flow from operations.

Net cash flows from investing activities were -3 MNOK in Q1-25 compared to -1 MNOK in Q1-24. This change is due to a small increase in purchases of equipment in this quarter compared to corresponding quarter last year.

Net cash flows from financing activities ended at -7 MNOK in Q1-25, compared to 164 MNOK during Q1-24. This change is primarily explained by use of proceeds from the private placement for downpayment of the overdraft facility in order to reduce interest cost.

Market Update

Market Update

Norcod's commercial strategy remains focused on premium positioning, consistent availability and strengthening market presence in selected high-value regions. As the Snow Cod brand gains traction, we continue focusing on a high share of contract-based sales, to reduce volatility in pricing and volume planning, while keeping a small share of product available to new customers and opportunities.

Looking ahead, the market outlook for farmed cod remains positive. With wild catch volumes expected to remain limited, demand for sustainable, traceable whitefish products is forecast to grow. The positive reception of Snow Cod in key markets has reinforced our premium positioning, and the company is therefor well positioned to meet evolving customer expectations while building longterm market partnerships.

Outlook

Outlook

Driven by favourable market conditions and strong sales price trends, the company has seen improvements in its financial performance.

By maintaining a sharp focus on cod biology, optimising the feeding regime, refining production processes, maximising production capacity and capitalising on scale-up effects, Norcod has developed a revised and profitable growth strategy that aligns with the favourable market dynamics.

To fund annual production capacity of up to 25,000 tonnes WFE towards 2030, Norcod has during Q1 2025 Norcod secured a funding of approximately 300 MNOK through a combination of increased debt commitment and private placement.

Although Norcod recognises that instability in the world economy and geopolitical unrest pose risks for the company, Norcod firmly believes in favourable market conditions going forward. Continued focus on cost optimisation and operational efficiency will reinforce the profitability trajectory and provide a strong foundation in the ongoing commercialisation phase for farmed cod.

Financials

Interim condensed consolidated statement of comprehensive income

(Amounts
'000)
in
NOK
Note Q1
2025
Q1
2024
FY
2024
Operating
revenue
193
454
118
469
397
183
of
materials
Cost
858
171
103
024
373
036
Salaries
and
personnel
expenses
21
950
22
202
88
821
Depreciation
, amortization
and
impairment
9
829
8
967
36
550
Other
operating
expenses
43
121
32
141
121
485
Operating
expenses
246
759
166
334
619
892
profit/
Operating
loss(-)
before
fair
value
adj
. of
biomass
-53
305
-47
864
-222
709
value
adjustment
biomass
Fair
1 10
667
2
264
17
740
profit/loss
Operating
-42
638
-45
600
-204
969
profit/
Share
of
loss(-)
from
associates
financial
Net
items
2 0
-7
124
0
-9
415
0
-30
033
Profit/loss
before
tax
-49
762
016
-55
-235
003
Income
tax
expenses
0 0 0
profit/loss
for
the
period
Net
-49
762
016
-55
-235
003
Other
comprehensive
income
0 0 0
Total
comprehensive
for
the
period
income
-49
762
016
-55
-235
003

Interim condensed consolidated statement of financial position

(Amounts
'000)
in
NOK
Note Q1
- 2025
Q1
- 2024
2024
ASSETS
Non-current
assets
Concessions
licenses
, trademarks
and
similar
rights
, patents,
2
000
2
000
2
000
, plant
&
equipment
Property
143
970
144
968
145
933
Right-of-use
assets
188
402
194
273
193
127
Other
investments
3 3 505 3
Total
non-current
assets
334
376
341
745
341
064
Current
assets
Inventories 1 8
971
7
086
13
242
Biological
assets
1 178
818
243
839
264
423
Short-term
receivables
33
701
49
938
15
868
Cash
and
cash
equivalents
4 8
580
140
859
22
533
Total
current
assets
230
070
441
723
316
066
TOTAL
ASSETS
564
446
783
468
657
130

Interim condensed consolidated statement of financial position

(Amounts
'000)
in
NOK
Note Q1
- 2025
Q1
- 2024
2024
EQUITY
AND
LIABILITIES
Equity
Share
capital
28
764
21
797
21
902
Shares
Treasury
-3
707
-3
707
-3
707
Share
premium
265
1
154
003
472
1
005
143
1
Retained
earnings
-917
008
-687
259
-867
246
Total
equity
262
314
334
304
156
092
Liabilities
interest-bearing
debt
Non-current
4 16
443
30
115
17
018
liabilities
Lease
4 104
998
120
286
111
156
Total
liabilities
non-current
121
441
150
401
128
174
leasing
Liabilities
Current
33
675
32
156
34
661
interest-bearing
debt
Current
51
931
128
119
205
270
Trade
payables
62
887
107
408
119
981
Other
liabilities
current
32
199
31
080
12
952
Total
liabilities
current
180
691
298
764
372
864
TOTAL
EQUITY
LIABILITIES
AND
564
446
783
468
657
130

Interim condensed consolidated statement of changes in equity

(Amounts
'000)
in
NOK
Paid-in
equity
Other
equity
Share shares Share Retained Total
2024 capital Treasury premium earnings equity
as of
Equity
1
Jan
2024
14
714
-3
707
846
042
-632
242
224
806
of
shares
Issue
11
03
2024
773 17
184
17
957
of
shares
Issue
20
03
2024
6
310
140
246
146
556
of
shares
04
2024
Issue
15
105 671
1
776
1
profit/loss
for
the
Net
year
-235
003
-235
003
Equity
of
31
Dec
2024
as
21
902
-3
707
1
005
143
-867
246
156
092
Retained
2025 Share
capital
shares
Treasury
Share
premium
earnings Total
equity
as of
Equity
1
Jan
2025
21
902
-3
707
1
005
143
-867
246
156
092
of
shares
Issue
24
03
2025
6
862
149
122
155
984
profit/loss
for
the
Net
year
-49
762
-49
762
of
March
Equity
31
2025
as
28
764
-3
707
1
154
265
-917
009
262
314

Interim condensed consolidated statement of cash flows

Q1
- 2025
Q1
- 2024
2024
FY
(Amounts
in NOK '000)
Note
Profit/loss
before
tax
-49
762
016
-55
-235
003
paid
Taxes
0 0 0
flow
from
Cash
operating
activities
0
and
Depreciation
amortization
9
829
8
967
36
550
of
intangible
Impairment
assets
3 0 0 502
Change
in
inventory
and
biological
assets
1 100
544
31
483
20
220
value
adjustment
Fair
1 -10
667
-2
264
-17
740
Change
in
receivable
accounts
-18
887
-15
125
15
685
Change
payable
in
accounts
-57
094
-28
455
-15
882
Change
other
receivables
and
other
liabilities
in
current
current
21
640
19
416
9
557
cash
flow
from
Net
operating
activities
-4
397
-40
993
-186
111
flows
from
Cash
investing
activities
for
purchase
of
plant
Payments
&
equipment
property,
-2
784
-1
186
-15
336
Proceeds
from
sale
of
plant
&
equipment
property,
0 0 4
228
flow
from
Net
cash
investing
activities
-2
784
-1
186
-11
107
Cash
flows
from
financing
activities
Receipts
from
debt
new non-current
0 0 3
500
change
bank
overdraft
Net
in
-153
348
8
763
68
701
of
debt
Repayment
-575 -344 -1
461
of
lease
liability
Repayment
-7
208
-4
382
-24
732
Interest
paid
2 -1
626
-4
290
-11
322
Proceeds
from
of
shares
issues
155
984
164
513
166
289
cash
flow
from
financing
Net
activities
-6
773
164
260
200
975
(decrease)/increase
cash
and
cash
equivalents
Net
in
-13
953
122
082
3
757
Cash
cash
equivalents
the
beginning
of
the
and
period
at
22
533
18
777
18
777
of
Cash
and
cash
equivalents
close
the
period
at
8
580
140
859
22
533

General information and accounting principles

Norcod (the Group) consists of Norcod AS, Norcod Equipment AS, Kråkøy Norcod AS and Kråkøy Norcod Eiendom AS . The Groups head office is located at Thomas Angells gate 22 in Trondheim, Norway. Norcod AS is listed on the Oslo Stock Exchange Euronext Growth under the ticker NCOD.

The condensed, consolidated interim financial statements have been drawn up in accordance with International Financial Reporting Standards (IFRS), including the International Accounting Standards 34 (IAS34) for interim financial reporting and are authorized for issue by the board of directors on 11 Jun 2025. The Group's accounting principles and calculation methods used in the most recent annual accounts are described in the annual report for 2024. No accounting principles have been changed or other standards have been adopted during the period. The annual report is published on www.norcod.no.

The condensed consolidated interim financial statements have not been audited. As a result of rounding differences, numbers or percentages may not add up to the total.

All figures in the notes are in NOK 1 000, unless otherwise specified.

Note 1 Inventories and biological assets

31
03
2025
31
03
2024
31
12
2024
Book
value
of
inventories
Feed
and
other
materials
8
971
7
086
13
242
Total
inventories
8
971
7
086
13
242
Book
value
of
biological
assets
and
cod
fry
Roe
at
cost
35
750
29
766
17
878
Biological
held
sea farms
assets
at
at
cost
236
891
334
039
351
035
Total
Biological
before
fair
value
adjustment
assets
272
641
363
805
368
913
value
adjustment
of
biological
Fair
assets
-93
823
-119
966
-104
490
Total
biological
assets
178
818
243
839
264
423
Q1
- 2025
Q1
- 2024
FY
2024
Reconciliation
of
changes
of
biological
in
carrying
amount
assets
of
comprehensive
Statement
income
post
balance
biological
Opening
assets
264
423
272
052
272
052
resulting
from
production
the
period
in
Increase
of
materials
Cost
78
898
79
679
386
393
Reduction
due
extraordinary
mortality
to
-2
401
0 -28
896
of
Fair
value
adjustment
biomass
Fair
value
adjustment
biomass
10
667
2
264
740
17
Reduction
due
harvesting
in
the
period
to
-172
769
-110
156
-382
866
Closing
balance
biological
assets
178
818
243
839
264
423
(1
kg)
Volumes
of
biological
in
000
assets
sea
balance
biological
Opening
in
assets
sea
6
746
7
817
7
817
Closing
balance
biological
in
assets
sea
4
013
6
640
6
746

The group had no uninvoiced finished goods in Q1 2025.

Note 1 Inventories and biological assets

Biological Assets

Biological assets are, in accordance with IAS 41 Agriculture, measured at fair value in accordance with IFRS 13. Biomass measured at fair value, is categorized at Level 3 in the fair value hierarchy, as the input is mostly unobservable. All cod at sea are subject to a fair value calculation, while roe and cod fry are measured at cost as cost is deemed a reasonable approximation for fair value as there is little biological transformation.

The technical model used to calculate the fair value of biomass is a present value model. Present value is calculated on the basis of estimated revenues less production costs remaining until the cod is harvestable at the individual site. The cod is harvestable when it has reached the estimated weight required for harvesting specified in the company's budgets and plans. The estimated value is discounted to present value on the date of reporting. The expected biomass at harvest is calculated on the basis of the number of individuals held at sea farms on date of reporting, adjusted for expected mortality up until the point of harvest and multiplied by the fish's estimated weight at harvest. The price is calculated using the Group's best estimate of future prices and are not observable. The price includes the Group's best estimate of the future prices of cod liver and other products of the cod that will be sold. Prices are adjusted for expected costs related to harvesting, sales and carriage costs. The Group applies a monthly discount rate of 2 %.

Estimated remaining production costs are estimated costs that a market participant would presume necessary for the farming of fish up until they reach a harvestable weight. In the model, instead of being a separate cost element in the calculation, compensation for estimated license fees and site leasing costs is included in the discount factor, and thereby reduces the fair value of the biomass.

The fair value of the biomass is calculated using a monthly discounting of the cash flow based on an expected harvesting month according to the harvesting plan. The discount factor is intended to reflect three main components:

    1. The risk of incidents that affect the cash flow
    1. The time value of money
    1. Synthetic license fees and site leasing costs

The discount factor is set on the basis of an average for all the Group's sites and which, in the Group's assessment, provides a sensible growth curve for the fish – from cod fry to harvestable fish.

The risk adjustment must take account of the risk involved in investing in live fish. Currently the Group expects a cod to spend on average 16-18 months at a sea farm, and the risk will be higher the longer the time until harvest. Biological risk, the risk of increased costs and price risk will be the most important elements to be recognized. The present value model includes a theoretical compensation for license fees and site leasing costs as a surplus to the discount factor in the model, instead of being a cost-reducing factor in the calculation.

Note 2 Financial items

Q1
- 2025
Q1
- 2024
FY
2024
Financial
income
Other
financial
income
9 59 1
240
Total
financial
income
9 59 1
240
Financial
expenses
Impairment
of
financial
assets
0 0 502
on long
loans
from
credit
Interest
institutions
term
4
037
3
644
12
872
expenses leasing
Interest
1
626
4
289
11
032
Adjustments
due
currency loss
to
286 1
024
2
147
Other
financial
expenses
1
184
517 4
721
Total
financial
expenses
7
133
9
474
31
274
financial
items
Net
124
-7
-9
415
-30
033

Note 3 Associated companies and other investments

Norcod previously held an investment in Arctic Cod AS, with book value of 0. The investment has been impaired by 502 TNOK in 2024, and Norcod's stake was sold out during the year and settled at book values.

As of 31.03.2025, Norcod does not hold any investments in associated companies.

Note 4 Interest-bearing liabilities

31
03
2025
31
03
2024
31
12
2024
interest-bearing
liabilities
Non-Current
interest-bearing
debt
Non-current
16
443
30
115
17
018
liabilities
for
right-of-use
Non
current
assets
104
998
120
286
111
156
leasing
liabilities
Non-current
121
441
150
401
128
174
interest-bearing
debt:
Current
liabilities
for
right-of-use
Current
assets
33
675
32
156
34
661
interest-bearing
debt
Current
51
931
128
119
205
270
Total
interest-bearing
debt
current
85
606
160
275
239
931
Total
interest-bearing
debt
207
046
310
676
368
105
Cash
and
bank
deposits
8
580
140
859
22
533
interest-bearing
debt
Net
198
467
169
817
345
572

Talk to a Data Expert

Have a question? We'll get back to you promptly.